Logo



 

  (format: symbol-exchange code e.g. IBM-N)

Exchange Codes:  T-Toronto N-New York A-American Q-Nasdaq I-Index
  • Stock Trends Report
  • Charting
  • Industry
  • Profile
  • Social
NYSE PILL
week ending
Friday Jul 10, 2020
   
Direxion Daily Pharmaceutical & Medical
Trend Trend Counters Relative Strength  
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal.
Trend / Category
9/ 12
13 week Current wk Unusual Volume
119 - Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks.
  weeks in vs. S&P500  
Trading stats for the Week Stock Trends chart of Direxion Daily Pharmaceutical & Medical  $PILL - click for more ST charts
  Close Range
$US 15.62 14.90 - 16.45
1 week %change 13 week %change
+1.4% +36.3%
Average Price
13 week MA 40 week MA
14.71 17.32
52-week range
6.55 - 29.70
Share Volume Relative Volume
205,400 136.9%
Total traded value
$3,208,348
Historical ST Data | ST Charts
Direxion Daily Pharmaceutical & Medical  (PILL-N)
Trend Rel
Str
+
-
52wk
Hi | Lo
Stock Name
Symbol
Wk Close
Wk
%Chg
Wk
Range
Vol (00's)
Hi/Lo Vol
No Stock Data
Highlighted stocks traded at their 52 week high or low, OR gained/lost more than 10% during the trading week.
Business Description :
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Dynamic Pharmaceutical Intellidex Index (the "index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index consists of common shares of companies that are principally engaged in research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
Company Website :
  Privacy Policy  |   Terms of Use  |   Syndications  |   Contact Us